Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Meobloc 100 - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Meobloc 100

Approved

STANDARD

Meobloc 100

Phil. United Pharma Corporation🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: a79dd9edcfbd4cbf
Company: Phil. United Pharma Corporation
Type: Standard

Approval Details

Approval Id: a79dd9edcfbd4cbf
Drug Approval Philippines Name: Meobloc 100
Product Name: Meobloc 100
Registration Number: DRP-13314
Brand Name: Meobloc 100
Generic Name: Metoprolol Tartrate
Dosage Form: Tablet
Dosage Strength: 100 mg
Manufacturer: Phil. United Pharma Corporation
Distributor: A.T.C. Healthcare International Corp.
Issuance Date: 26 January 2023
Expiry Date: 26 January 2028
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

a79dd9edcfbd4cbf

Type

Standard

Back to Philippines FDA Approvals